Status:
UNKNOWN
Global Registry to Gather Data on Natural History of Patients With Hereditary Angioedema Type I and II
Lead Sponsor:
HAE Global Registry Foundation
Conditions:
Hereditary Angioedema Type I and II
Eligibility:
All Genders
Brief Summary
The objective of this international hereditary angioedema (HAE) register is to collect homogeneous clinical and laboratory data on patients with HAE type I and II gathering better information on the n...
Detailed Description
It is an international multicenter disease registry, the principal investigator at each center is responsible for competent ethic committee/institutional review board approval and for identifying co-i...
Eligibility Criteria
Inclusion
- patients diagnosed with HAE type I and II with signed informed consent
- laboratory diagnostic criteria documenting plasma levels of C1 inhibitor antigen and function and of C4 antigen
Exclusion
- patients without HAE type I and II
- patients without documented laboratory diagnostic criteria
- patients not capable to give informed consent
Key Trial Info
Start Date :
October 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT03828279
Start Date
October 1 2017
End Date
December 31 2023
Last Update
February 5 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ASST FBF Sacco
Milan, Italy, 20157